Success Metrics

Clinical Success Rate
100.0%

Based on 22 completed trials

Completion Rate
100%(22/22)
Active Trials
0(0%)
Results Posted
45%(10 trials)

Phase Distribution

Ph phase_1
3
13%
Ph not_applicable
2
9%
Ph phase_3
14
61%
Ph phase_2
3
13%

Phase Distribution

3

Early Stage

3

Mid Stage

14

Late Stage

Phase Distribution22 total trials
Phase 1Safety & dosage
3(13.6%)
Phase 2Efficacy & side effects
3(13.6%)
Phase 3Large-scale testing
14(63.6%)
N/ANon-phased studies
2(9.1%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

95.7%

22 of 23 finished

Non-Completion Rate

4.3%

1 ended early

Currently Active

0

trials recruiting

Total Trials

23

all time

Status Distribution
Completed(22)
Terminated(1)

Detailed Status

Completed22
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
23
Active
0
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Phase 13 (13.6%)
Phase 23 (13.6%)
Phase 314 (63.6%)
N/A2 (9.1%)

Trials by Status

completed2296%
withdrawn14%

Recent Activity

Clinical Trials (23)

Showing 20 of 23 trialsScroll for more
NCT04320342Phase 3

A Study Comparing Efficacy, Safety and Tolerability of the Fixed Dose Triple Combination CHF 5993 With the Fixed Dose Dual Combination CHF 1535 in Subjects With COPD

Completed
NCT05292586Phase 3

A Study Testing the Superiority of CHF 1535 pMDI 800/24µg Total Daily Dose Compared With CHF 718 pMDI 800µg Total Daily Dose in Adults With Asthma on Medium or High-Dose Inhaled Corticosteroid

Completed
NCT04873063Phase 1

Evaluation of Systemic Bioavailability and Effects on 24-Hour Plasma Cortisol Profile of 6 mg Delivered Once Daily Versus 3 mg Delivered Twice Daily in Healthy Adult Male Volunteers

Completed
NCT01024608Phase 3

Study in Adult and Adolescent Subjects With Seasonal Allergic Rhinitis (SAR)

Completed
NCT00988247Phase 3

Long Term Safety and Efficacy Trial of Beclomethasone Dipropionate - Hydrofluoroalkane (BDP-HFA) 320 mcg in Allergic Rhinitis

Completed
NCT00094016Phase 3

Evaluation of Two Doses of QVAR by Breath Operated and Metered Dose Inhalers in Asthmatic Children

Completed
NCT02139644Phase 3

Study of Fluticasone Propionate MDPI Compared With Fluticasone/Salmeterol MDPI in Adolescent and Adult Patients With Persistent Asthma

Completed
NCT02031640Phase 3

A Safety and Efficacy Study of Beclomethasone Dipropionate Delivered Via Breath-Actuated Inhaler (BAI) or Metered-Dose Inhaler (MDI) in Participants >=12 Years Old With Persistent Asthma

Completed
NCT00000752Phase 2

Preventing Frequent Sinus Infections in HIV-Infected Patients

Withdrawn
NCT00489203Phase 2

Beclomethasone Dipropionate in Preventing Acute Graft-Versus-Host Disease in Patients Undergoing a Donor Stem Cell Transplant for Hematologic Cancer

Completed
NCT00497523Phase 3

Efficacy and Safety of Nebulised Beclomethasone Dipropionate Plus as Needed Salbutamol vs as Needed Salbutamol or as Needed Salbutamol/Beclomethasone Fixed Combination in Young Children With Asthma Symptoms

Completed
NCT01142947Not Applicable

Study of Asthma Phenotypes and Pharmacogenomic Interactions by Race-Ethnicity (SAPPHIRE)

Completed
NCT00565266Phase 3

Asthma Clinical Research Network (ACRN) Trial - Tiotropium Bromide as an Alternative to Increased Inhaled Corticosteroid in Patients Inadequately Controlled on a Lower Dose of Inhaled Corticosteroid (TALC)

Completed
NCT00394329Phase 3

(CARE Network Trial - Treating Children to Prevent Exacerbations of Asthma (TREXA)

Completed
NCT00346775Phase 3

Validation Of Preference Module Of Experience With Allergic Rhinitis Nasal Sprays Questionnaire (EARNS-Q)

Completed
NCT00043147Phase 3

Beclomethasone Plus Prednisone in Treating Patients With Graft-Versus-Host Disease

Completed
NCT01141439

Real-world Effectiveness and Cost-effectiveness of Leading Inhaled Corticosteroids in Asthma Management

Completed
NCT01016223Phase 1

A Randomized Double Blind Placebo Controlled Study of the Effect of Swallowed Beclomethasone Dipropionate on Inflammatory Markers in Adult Patients With Eosinophilic Esophagitis

Completed
NCT01133626Phase 3

Hypothalamic-Pituitary-Adrenal (HPA) Axis Study in Adult and Adolescent Subjects With Perennial Allergic Rhinitis (PAR)

Completed
NCT00055666Not Applicable

Compassionate Use of Beclomethasone in Treating Patients With Graft-Versus-Host Disease of the Gastrointestinal Tract

Completed

Drug Details

Intervention Type
DRUG
Total Trials
23